Generation of functional antigen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2002-04-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.092154599PMID 11983911PMCID PMC122927
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes.

  2009cited by this paper
• V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations.

  2001cited by this paper
• Mixed chimerism and transplant tolerance.

  2001cited by this paper
• Factors and forces controlling V(D)J recombination.

  2001cited by this paper
• Immunotherapy through TCR gene transfer

  2001cited by this paper
• Premature TCRαβ Expression and Signaling in Early Thymocytes Impair Thymocyte Expansion and Partially Block Their Development

  2001cited by this paper
• Premature TCR alpha beta expression and signaling in early thymocytes impair thymocyte expansion and partially block their development.

  2001cited by this paper
• Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer

  2001cited by this paper
• The T-cell repertoire available for recognition of self-antigens.

  2001cited by this paper
• Retroviruses as tools to study the immune system.

  2001cited by this paper
• The RAG proteins and V(D)J recombination: complexes, ends, and transposition.

  2000cited by this paper
• Functional Reconstitution of Class II MHC-Restricted T Cell Immunity Mediated by Retroviral Transfer of the αβ TCR Complex1

  2000cited by this paper
• Transfer of Specificity for Human Immunodeficiency Virus Type 1 into Primary Human T Lymphocytes by Introduction of T-Cell Receptor Genes

  2000cited by this paper
• Retroviral Expression in Embryonic Stem Cells and Hematopoietic Stem Cells

  2000cited by this paper
• Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the alpha beta TCR complex.

  2000cited by this paper
• Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity.

  1999cited by this paper
• Linear differentiation of cytotoxic effectors into memory T lymphocytes.

  1999cited by this paper
• Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death.

  1999cited by this paper
• Different modes of pathogenesis in T‐cell‐dependent autoimmunity: clues from two TCR transgenic systems

  1999cited by this paper
• Structural basis of T cell recognition.

  1999cited by this paper
• Defective TCR expression in transgenic mice constructed using cDNA‐based α‐ and β‐chain genes under the control of heterologous regulatory elements

  1998cited by this paper
• Thymocytes can become mature T cells without passing through the CD4+ CD8+, double-positive stage

  1996cited by this paper
• The alpha beta T cell receptor can replace the gamma delta receptor in the development of gamma delta lineage cells.

  1996cited by this paper
• Biophysical studies of T-cell receptors and their ligands.

  1996cited by this paper
• The αβ T Cell Receptor Can Replace the γδ Receptor in the Development of γδ Lineage Cells

  1996cited by this paper
• Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment.

  1995cited by this paper
• Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta.

  1995cited by this paper
• Immunol. Cell Biol.

  1995cited by this paper
• Cassette vectors directing expression of T cell receptor genes in transgenic mice.

  1995cited by this paper
• LacZ inducible, antigen/MHC-specific T cell hybrids.

  1994cited by this paper
• Versatile retroviral vectors for potential use in gene therapy.

  1994cited by this paper
• Regulation of adhesion molecule expression by CD8 T cells in vivo. II. Expression of L-selectin (CD62L) by memory cytolytic T cells responding to minor histocompatibility antigens.

  1994cited by this paper
• Production of high-titer helper-free retroviruses by transient transfection.

  1993cited by this paper
• Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity.

  1993cited by this paper
• Following a diabetogenic T cell from genesis through pathogenesis.

  1993cited by this paper
• Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

  1993cited by this paper
• RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement.

  1992cited by this paper
• RAG-1-deficient mice have no mature B and T lymphocytes.

  1992cited by this paper
• Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.

  1991cited by this paper
• Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction.

  1991cited by this paper
• An unusual lineage of alpha/beta T cells that contains autoreactive cells

  1991cited by this paper
• Developmental biology of T cells in T cell-receptor transgenic mice.

  1990cited by this paper
• Developmental biology of T cells in T cell-receptor transgenic mice.

  1990cited by this paper
• The V(D)J recombination activating gene, RAG-1.

  1989cited by this paper
• T cell memory. Long-term persistence of virus-specific cytotoxic T cells

  1989cited by this paper
• Blood.

  1989cited by this paper
• Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand.

  1989cited by this paper
• CD44 contributes to T cell activation.

  1989cited by this paper
• Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen

  1989cited by this paper
• Thymic major histocompatibility complex antigens and the αβ T-cell receptor determine the CD4/CD8 phenotype of T cells

  1988cited by this paper
• Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes

  1988cited by this paper
• T-cell-specific deletion of T-cell receptor transgenes allows functional rearrangement of endogenous alpha- and beta-genes.

  1988cited by this paper
• Thymic major histocompatibility complex antigens and the alpha beta T-cell receptor determine the CD4/CD8 phenotype of T cells.

  1988cited by this paper
• T-cell-specific deletion of T-cell receptor transgenes allows functional rearrangement of endogenous α- and β-genes

  1988cited by this paper
• Positive and negative selection of an antigen receptor on T cells in transgenic mice

  1988cited by this paper
• A T3-like protein complex associated with the antigen receptor on murine T cells

  1986cited by this paper
• A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains

  1984cited by this paper
• Isolation of cDNA clones encoding T cell-specific membrane-associated proteins

  1984cited by this paper
• Reprints Available Directly from the Publisher Photocopying Permitted by License Only Positive and Negative Selection in Transgenic Mice Expressing a T-cell Receptor Specific for Influenza Nucleoprotein and Endogenous Superantigen

  year unknowncited by this paper

• Induction of antigen-specific regulatory T cells by engineered extracellular vesicles

  2025cites this paper
• Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny

  2025cites this paper
• Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency

  2024cites this paper
• A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for in vitro screening of immunomodulatory checkpoints and therapeutics

  2023cites this paper
• Advancing cell-based cancer immunotherapy through stem cell engineering.

  2023cites this paper
• Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency

  2023cites this paper
• Engineering stem cells for cancer immunotherapy.

  2021cites this paper
• Genetically modified hematopoietic stem/progenitor cells that produce IL-10–secreting regulatory T cells

  2019cites this paper
• Targeting cancers through TCR-peptide/MHC interactions

  2019cites this paper
• Generation of T Cell Receptor Retrogenic Mice

  2019cites this paper
• Applications of molecular engineering in T-cell-based immunotherapies.

  2019cites this paper
• Sixty Years of Discovery.

  2019cites this paper
• A Pilot Trial of the Combination of Transgenic NY-ESO-1–reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab

  2018cites this paper
• Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products

  2018cites this paper
• IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System

  2018cites this paper
• The hu-mice were made by intravenous injection of TCR-engineered HLA-A * 0201 + CD 34 + FLCs into NOD

  2016cites this paper
• Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice

  2016cites this paper
• Genetic engineering of hematopoietic stem cells to generate invariant natural killer T cells

  2015cites this paper
• Immunotherapy with TCR-Redirected T Cells: Comparison of TCR-Transduced and TCR-Engineered Hematopoietic Stem Cell–Derived T Cells

  2014cites this paper
• Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma

  2014cites this paper
• IL‐13Rα1 is a surface marker for M2 macrophages influencing their differentiation and function

  2014cites this paper
• TCR-Engineered Hematopoietic Stem Cell Cells : Comparison of TCR-Transduced and Immunotherapy with TCR-Redirected T

  2013cites this paper
• Introduction of exogenous T-cell receptors into human hematopoietic progenitors results in exclusion of endogenous T-cell receptor expression.

  2013cites this paper
• Retroviral transduction of lineage antigen-negative ((Lin−) cells: a valuable alternative for the generation of T cell receptor (TCR) retrogenic mice.

  2012cites this paper
• CD4+ T cell mediated tumor immunity following transplantation of TRP-1 TCR gene modified hematopoietic stem cells

  2012cites this paper
• T‐cell receptor retrogenic mice: a rapid, flexible alternative to T‐cell receptor transgenic mice

  2012cites this paper
• Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells

  2011cites this paper
• Stem cell-based anti-HIV gene therapy.

  2011cites this paper
• Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunity.

  2010cites this paper
• Overcoming barriers to programming a therapeutic cellular immune response to fight melanoma

  2010cites this paper
• Subtle Affinity-Enhancing Mutations in a Myelin Oligodendrocyte Glycoprotein-Specific TCR Alter Specificity and Generate New Self-Reactivity1

  2009cites this paper
• Lentiviral calnexin‐modified dendritic cells promote expansion of high‐avidity effector T cells with central memory phenotype

  2009cites this paper
• In Vitro Differentiation of Adult Bone Marrow Progenitors into Antigen-Specific CD4 Helper T Cells Using Engineered Stromal Cells Expressing a Notch Ligand and a Major Histocompatibility Complex Class II Protein

  2009influential citation
• Engineering Antigen-Specific T Cells from Genetically Modified Human Hematopoietic Stem Cells in Immunodeficient Mice

  2009cites this paper
• Retrogenic Modeling of Experimental Allergic Encephalomyelitis Associates T Cell Frequency but Not TCR Functional Affinity with Pathogenicity1

  2008cites this paper
• Gamma‐retroviral vectors enveloped with an antibody and an engineered fusogenic protein achieved antigen‐specific targeting

  2008cites this paper
• Enhancing T cell reconstitution after hematopoietic stem cell transplantation: a brief update of the latest trends.

  2008cites this paper
• with Pathogenicity Frequency but Not TCR Functional Affinity Allergic Encephalomyelitis Associates T Cell Retrogenic Modeling of Experimental

  2008cites this paper
• Multiple Levels of Selection Responsive to Immunoglobulin Light Chain and Heavy Chain Structures Impede the Development of Dμ-Expressing B Cells1

  2008influential citation
• Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors

  2008cites this paper
• The T-body approach: redirecting T cells with antibody specificity.

  2008cites this paper
• Redirecting T lymphocyte specificity by T cell receptor gene transfer--a new era for immunotherapy.

  2007cites this paper
• T-cell receptor gene therapy for cancer: the progress to date and future objectives

  2007cites this paper
• Monoclonal T-cell receptors: new reagents for cancer therapy.

  2007cites this paper
• Precursor B Cell Receptor Signaling Activity Can Be Uncoupled from Surface Expression1

  2006influential citation
• Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases

  2006cites this paper
• Adult Stem Cells and Gene Therapy

  2006cites this paper
• Moyens et procedes de generation d'un lymphocyte t dirige contre un antigene d'interet

  2006cites this paper
• Can Be Uncoupled from Surface Expression Precursor B Cell Receptor Signaling Activity

  2006influential citation
• Rapid analysis of T-cell selection in vivo using T cell–receptor retrogenic mice

  2006cites this paper
• Selective Requirement of p38α MAPK in Cytokine-Dependent, but Not Antigen Receptor-Dependent, Th1 Responses1

  2006cites this paper
• Towards immunogene therapy of hematological malignancies.

  2006cites this paper
• Receptor-Dependent , Th 1 Responses Cytokine-Dependent , but Not Antigen MAPK in α Selective Requirement of p 38

  2006cites this paper
• Gene modification strategies to induce tumor immunity.

  2005cites this paper
• Fulminant experimental autoimmune encephalo‐myelitis induced by retrovirally mediated TCR gene transfer

  2005cites this paper
• Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells.

  2005cites this paper
• Supernatural T cells: genetic modification of T cells for cancer therapy

  2005cites this paper
• Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution.

  2005cites this paper
• STAT 5-Dependent Mechanism Cytokine-Producing Capacity in Eosinophils Cutting Edge : IL-5 Primes Th 2

  2004cites this paper
• Cutting Edge: IL-5 Primes Th2 Cytokine-Producing Capacity in Eosinophils through a STAT5-Dependent Mechanism1

  2004cites this paper
• Two isoforms of otubain 1 regulate T cell anergy via GRAIL

  2004cites this paper
• An efficient method to prepare T cell receptor gene‐transduced cytotoxic T lymphocytes type 1 applicable to tumor gene cell‐therapy

  2003cites this paper
• Targeting tumours with genetically enhanced T lymphocytes

  2003cites this paper
• Prospects for immunotherapy of malignant disease

  2003cites this paper
• Novel approaches to identify T cell-recognized tumor antigens and to redirect T cells for adoptive immunotherapy

  2003cites this paper
• MHC-UNRESTRICTED MUC1-SPECIFIC T CELL RECEPTOR FOR CANCER IMMUNOTHERAPY/GENE THERAPY

  2003cites this paper